Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study

Peer Review reports

Original Submission
22 Apr 2022	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
11 Jul 2022	Reviewed	Reviewer Report
19 Jul 2022	Reviewed	Reviewer Report - Toshinobu Hayashi
6 Aug 2022	Author responded	Author comments - Luigi Celio
Resubmission - Version 3
6 Aug 2022	Submitted	Manuscript version 3
Publishing
18 Aug 2022	Editorially accepted
24 Aug 2022	Article published	10.1186/s12885-022-10018-3

Back to article page